Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


13.11.2017

1 Am J Epidemiol
2 Ann Intern Med
1 Clin Infect Dis
3 Eur Respir J
1 J Antimicrob Chemother
1 J Bacteriol
1 J Clin Microbiol
18 J Infect Dis
2 Lancet Infect Dis
2 PLoS Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. SANDERSON SLUTSKER J, Trieu L, Crossa A, Desai Ahuja S, et al
    Using Reports of Latent Tuberculosis Infection Among Young Children to Identify Tuberculosis Transmission in New York City, 2006-2012.
    Am J Epidemiol. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. BELKNAP R, Holland D, Feng PJ, Millet JP, et al
    Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
    Ann Intern Med. 2017 Nov 7. doi: 10.7326/M17-1150.
    PubMed     Text format     Abstract available

  3. GETAHUN H, Matteelli A
    Tailoring Treatment of Latent Tuberculosis to the Needs of Patients and Families.
    Ann Intern Med. 2017 Nov 7. doi: 10.7326/M17-2639.
    PubMed     Text format    


    Clin Infect Dis

  4. GRIESEL R, Stewart A, van der Plas H, Sikhondze W, et al
    Optimizing Tuberculosis Diagnosis in HIV-Infected Inpatients Meeting the Criteria of Seriously Ill in the WHO Algorithm.
    Clin Infect Dis. 2017 Nov 6. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  5. FURIN J, Lessem E, Cox V
    Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis.
    Eur Respir J. 2017;50.
    PubMed     Text format    

  6. KUKSA L, Barkane L, Hittel N, Gupta R, et al
    Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
    Eur Respir J. 2017;50.
    PubMed     Text format    

  7. FALZON D, Migliori GB, Jaramillo E, Weyer K, et al
    Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    J Antimicrob Chemother

  8. YEW WW, Leung CC, Zhang Y
    Oxidative stress and TB outcomes in patients with diabetes mellitus?
    J Antimicrob Chemother. 2017;72:1552-1555.
    PubMed     Text format     Abstract available


    J Bacteriol

  9. GILBERT S, Hood L, Seah SYK
    Characterization of an aldolase involved in cholesterol side chain degradation in Mycobacterium tuberculosis.
    J Bacteriol. 2017 Nov 6. pii: JB.00512-17. doi: 10.1128/JB.00512.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  10. LIANG B, Tan Y, Li Z, Tian X, et al
    Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay.
    J Clin Microbiol. 2017 Nov 8. pii: JCM.01239-17. doi: 10.1128/JCM.01239.
    PubMed     Text format     Abstract available


    J Infect Dis

  11. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    

  12. CHIN DP, Hanson CL
    Finding the Missing Tuberculosis Patients.
    J Infect Dis. 2017;216.
    PubMed     Text format    

  13. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  14. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  15. TURNER RD, Chiu C, Churchyard GJ, Esmail H, et al
    Tuberculosis Infectiousness and Host Susceptibility.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  16. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  17. SURYA A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, et al
    Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  18. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  19. SISMANIDIS C, Shete PB, Lienhardt C, Floyd K, et al
    Harnessing the Power of Data to Guide Local Action and End Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format    

  20. FEKADU L, Hanson C, Osberg M, Makayova J, et al
    Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  21. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    

  22. FATIMA R, Haq MU, Yaqoob A, Mahmood N, et al
    Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand Tuberculosis-Related Care Seeking in Pakistan.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  23. MASINI E, Hanson C, Ogoro J, Brown J, et al
    Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  24. HANSON CL, Osberg M, Brown J, Durham G, et al
    Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  25. HANSON C, Osberg M, Brown J, Durham G, et al
    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  26. GARFIN C, Mantala M, Yadav R, Hanson CL, et al
    Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  27. SALVATORE PP, Proano A, Kendall EA, Gilman RH, et al
    Linking individual natural history to population outcomes in tuberculosis.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. DOWDY DW, Grant AD, Dheda K, Nardell E, et al
    Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  29. WHITE PJ, Abubakar I, Aldridge RW, Hayward AC, et al
    Post-migration follow-up of migrants at risk of tuberculosis.
    Lancet Infect Dis. 2017;17:1124.
    PubMed     Text format    

  30. ABEL L, Fellay J, Haas DW, Schurr E, et al
    Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives.
    Lancet Infect Dis. 2017 Oct 27. pii: S1473-3099(17)30623.
    PubMed     Text format     Abstract available


    PLoS Med

  31. RUDGARD WE, Evans CA, Sweeney S, Wingfield T, et al
    Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
    PLoS Med. 2017;14:e1002418.
    PubMed     Text format     Abstract available

  32. SHETE PB, Dowdy DW
    Measuring success: The challenge of social protection in helping eliminate tuberculosis.
    PLoS Med. 2017;14:e1002419.
    PubMed     Text format     Abstract available


    PLoS One

  33. HERZMANN C, Ernst M, Lange C, Stenger S, et al
    Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.
    PLoS One. 2017;12:e0187882.
    PubMed     Text format     Abstract available

  34. HE X, Cao M, Mahapatra T, Du X, et al
    Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study.
    PLoS One. 2017;12:e0187592.
    PubMed     Text format     Abstract available

  35. ARMSTRONG-HOUGH M, Turimumahoro P, Meyer AJ, Ochom E, et al
    Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.
    PLoS One. 2017;12:e0187145.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: